[1]Locationinpatent:schemeortableMowbray,CharlesE.;Burt,Catherine;Corbau,Romuald;Gayton,Simon;Hawes,Michael;Perros,Manos;Tran,Isabelle;Price,DavidA.;Quinton,FayeJ.;Selby,MatthewD.;Stupple,PaulA.;Webster,Rob;Wood,Anthony[BioorganicandMedicinalChemistryLetters,2009,vol.19,#20,p.5857-5860]
[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/57593,2013,A1Locationinpatent:Page/Pagecolumn3
[1]Cohen,DanielT.;Buchwald,StephenL.[OrganicLetters,2015,vol.17,#2,p.202-205]
[1]Cohen,DanielT.;Buchwald,StephenL.[OrganicLetters,2015,vol.17,#2,p.202-205]
Title: The effect of lersivirine, a next-generation NNRTI, on the pharmacokinetics of midazolam and oral contraceptives in healthy subjects.
Journal: European journal of clinical pharmacology 20121101
Title: Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
Journal: Drug and alcohol dependence 20121101
Title: Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects.
Journal: British journal of clinical pharmacology 20120501
Title: The pharmacokinetics of lersivirine (UK-453,061) and HIV-1 protease inhibitor coadministration in healthy subjects.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120501
Title: Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase.
Journal: Bioorganic & medicinal chemistry letters 20111215
Title: Comparison of the non-nucleoside reverse transcriptase inhibitor lersivirine with its pyrazole and imidazole isomers.
Journal: Chemical biology & drug design 20110501
Title: Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore.
Journal: Journal of medicinal chemistry 20101125
Title: Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1.
Journal: Antimicrobial agents and chemotherapy 20101001
Title: Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers.
Journal: Clinical therapeutics 20101001
Title: Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.
Journal: Antiviral chemistry & chemotherapy 20100811
Title: Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.
Journal: Retrovirology 20100101
Title: Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate.
Journal: Bioorganic & medicinal chemistry letters 20091015
Title: Mowbray CE, et al. Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate. Bioorg Med Chem Lett. 2009 Oct 15;19(20):5857-60.
Title: Gregg D Cappon, et al. Developmental toxicity study of lersivirine in mice. Birth Defects Res B Dev Reprod Toxicol. 2012 Jun;95(3):225-30.
